Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)
Year: 2017
Type: article
Study design: Case Report
Source: European Journal Of Haematology
DOI: 10.1111/ejh.12986
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2766219207
